Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Karyopharm Therapeut (KPTI)

Karyopharm Therapeut (KPTI)
0.5924 x 135 0.5982 x 6
Post-market by (Cboe BZX)
0.5981 -0.0219 (-3.53%) 02/11/25 [NASDAQ]
0.5924 x 135 0.5982 x 6
Post-market 0.5981 unch (unch) 16:00 ET
Quote Overview for Tue, Feb 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.5900
Day High
0.6424
Open 0.6300
Previous Close 0.6200 0.6200
Volume 1,133,681 1,133,681
Avg Vol 729,738 729,738
Stochastic %K 16.61% 16.61%
Weighted Alpha -58.62 -58.62
5-Day Change -0.0216 (-3.49%) -0.0216 (-3.49%)
52-Week Range 0.5809 - 1.7000 0.5809 - 1.7000
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 78,604
  • Shares Outstanding, K 126,191
  • Annual Sales, $ 146,030 K
  • Annual Income, $ -143,100 K
  • EBIT $ -126 M
  • EBITDA $ -129 M
  • 60-Month Beta 0.06
  • Price/Sales 0.52
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.14
  • Most Recent Earnings $-0.26 on 11/05/24
  • Next Earnings Date 03/06/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Options Overview Details

View History
  • Implied Volatility 448.64% ( +61.16%)
  • Historical Volatility 98.23%
  • IV Percentile 98%
  • IV Rank 78.24%
  • IV High 570.08% on 12/13/24
  • IV Low 11.90% on 08/22/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 145
  • Volume Avg (30-Day) 29
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 10,002
  • Open Int (30-Day) 9,910

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.26
  • Number of Estimates 4
  • High Estimate -0.19
  • Low Estimate -0.35
  • Prior Year -0.36
  • Growth Rate Est. (year over year) +27.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5900 +1.37%
on 02/11/25
Period Open: 0.7186
0.7400 -19.18%
on 01/13/25
-0.1205 (-16.77%)
since 01/10/25
3-Month
0.5809 +2.96%
on 12/26/24
Period Open: 0.9218
0.9495 -37.01%
on 11/12/24
-0.3237 (-35.12%)
since 11/11/24
52-Week
0.5809 +2.96%
on 12/26/24
Period Open: 1.3400
1.7000 -64.82%
on 03/08/24
-0.7419 (-55.37%)
since 02/09/24

Most Recent Stories

More News
Karyopharm Therapeutics (KPTI) Q3 2024 Earnings Call Transcript

KPTI earnings call for the period ending September 30, 2024.

KPTI : 0.5981 (-3.98%)
Karyopharm Therapeutics: Q3 Earnings Snapshot

Karyopharm Therapeutics: Q3 Earnings Snapshot

KPTI : 0.5981 (-3.98%)
Karyopharm Therapeutics (KPTI) Q2 2024 Earnings Call Transcript

KPTI earnings call for the period ending June 30, 2024.

KPTI : 0.5981 (-3.98%)
Karyopharm Therapeutics: Q2 Earnings Snapshot

Karyopharm Therapeutics: Q2 Earnings Snapshot

KPTI : 0.5981 (-3.98%)
Karyopharm Therapeutics (KPTI) Q1 2024 Earnings Call Transcript

KPTI earnings call for the period ending March 31, 2024.

KPTI : 0.5981 (-3.98%)
Karyopharm Therapeutics: Q1 Earnings Snapshot

Karyopharm Therapeutics: Q1 Earnings Snapshot

KPTI : 0.5981 (-3.98%)
Karyopharm Therapeutics (KPTI) Q4 2023 Earnings Call Transcript

KPTI earnings call for the period ending December 31, 2023.

KPTI : 0.5981 (-3.98%)
Karyopharm Therapeutics: Q4 Earnings Snapshot

Karyopharm Therapeutics: Q4 Earnings Snapshot

KPTI : 0.5981 (-3.98%)
Karyopharm Therapeutics (KPTI) Q3 2023 Earnings Call Transcript

KPTI earnings call for the period ending September 30, 2023.

KPTI : 0.5981 (-3.98%)
Karyopharm Therapeutics: Q3 Earnings Snapshot

Karyopharm Therapeutics: Q3 Earnings Snapshot

KPTI : 0.5981 (-3.98%)

Business Summary

Karyopharm Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on the discovery and development of drugs for the treatment of cancer and other major diseases. It serves the healthcare industry throughout the United States. Karyopharm Therapeutics, Inc. is based in United States.

See More

Key Turning Points

3rd Resistance Point 0.6988
2nd Resistance Point 0.6824
1st Resistance Point 0.6527
Last Price 0.5981
1st Support Level 0.6066
2nd Support Level 0.5902
3rd Support Level 0.5605

See More

52-Week High 1.7000
Fibonacci 61.8% 1.2725
Fibonacci 50% 1.1405
Fibonacci 38.2% 1.0084
Last Price 0.5981
52-Week Low 0.5809

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Optimizing Trade Entries with the Futures Trading Guide